Vanguard Group’s RESPONSE GENETICS, INC COMMON SHS (DELAWARE) RGDX Stock Holding History

Vanguard Group’s Portfolio RGDX Stock Details RGDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-636,920	Closed	-$208K	–	4256
2015 Q2	$208K	Buy	636,920 +17,200	+3%	+$5.82K	﹤0.01%	4041
2015 Q1	$285K	Buy	619,720 +7,100	+1%	+$3.16K	﹤0.01%	3939
2014 Q4	$194K	Sell	612,620 -37,871	-6%	-$20.9K	﹤0.01%	3912
2014 Q3	$446K	Sell	650,491 -600	-0.1%	-$470	﹤0.01%	3746
2014 Q2	$599K	Hold	651,091	–	–	﹤0.01%	3630
2014 Q1	$775K	Buy	651,091 +139,850	+27%	+$195K	﹤0.01%	3533
2013 Q4	$593K	Buy	511,241 +177,800	+53%	+$291K	﹤0.01%	3552
2013 Q3	$740K	Buy	+333,441	New	+$673K	﹤0.01%	3445

Vanguard Group's RGDX Position: Q3 2015 in Review

Vanguard Group sold out of RESPONSE GENETICS, INC COMMON SHS (DELAWARE) (RGDX) in Q3 2015, closing a stake of 636,920 shares — an estimated $208K sold.

Vanguard Group first reported a position in RGDX in Q3 2013 and held it in 8 quarters. The position peaked at $775K in Q1 2014. 1 fund tracked by Wall St. Rank holds RGDX as of Q3 2015.

Vanguard Group reported no remaining RESPONSE GENETICS, INC COMMON SHS (DELAWARE) position as of Q3 2015 after selling out during the quarter.
Vanguard Group sold 636,920 RESPONSE GENETICS, INC COMMON SHS (DELAWARE) shares in Q3 2015, an estimated $208K.
Vanguard Group first reported a position in RESPONSE GENETICS, INC COMMON SHS (DELAWARE) in Q3 2013 and held it in 8 quarters.
Vanguard Group's RESPONSE GENETICS, INC COMMON SHS (DELAWARE) position peaked at $775K in Q1 2014.
1 fund tracked by Wall St. Rank held RESPONSE GENETICS, INC COMMON SHS (DELAWARE) as of Q3 2015.

Based on Vanguard Group's 13F filing for Q3 2015, filed 12 Nov 2015.